Loading...
CMET-30. LEPTOMENINGEAL METASTASES: OUTCOMES WITH AGGRESSIVE MULTIMODALITY TREATMENT
INTRODUCTION: Leptomeningeal metastases (LM) affect 5–8% of cancer patients; median survivals historically have ranged from 12–16 weeks. Earlier intervention, multimodal treatment, intrathecal chemotherapy, and targeting relevant molecular drivers may improve outcomes. METHODS: Under an IRB-approved...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692985/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.177 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|